The Expression and Significance of c-myc and bcat1 in Cervical Cancer

WU Shou-heng, ZENG Xiao-feng, WANG Ping. et al

Abstract

To explore the relationship between c-myc and bcat1 expression and the occurrence, development and clinical features of cervical cancer. Methods The expression level of c-myc and bcat1 were detected in 30 cases of normal cervical tissues, 30 cases of CIN tissues, 40 cases of cervical squamous carcinoma tissues and 40 cases of cervical adenocarcinoma tissues by immunohistochemistry; Conduct a Spearman rank correlation analysis between c-myc and bcat1 expressions; Analyze the relationship between the expression of both genes and clinicopathological factors of cervical cancer. Results The positive rates of c-myc expression were 16.7% (5/30) in normal cervical tissues, 43.3% (13/30) in CIN tissues and 73.8% (59/80) in cervical cancer tissues, the positive rates of bcat1 expression were 10.0% (3/30) in normal cervical tissues, 23.3% (7/30) in CIN tissues and 52.5% (42/80) in cervical cancer tissues. The rank correlation index between c-myc and bcat1 is respectively 0.773 (P=0.000) in cervical squamous carcinoma and 0.369 (P=0.019) in adenocarcinoma. The positive expression rate of c-myc was related to the pathological type of cancer tissue (adenocarcinoma/squamous cell carcinoma), the degree of tumor tissue differentiation, the depth of interstitial infiltration, and the presence or absence of vascular invasion (P<0.05). The positive expression rate of bcat1 was related to the degree of tumor differentiation, vascular invasion and Ki67 index (P<0.05). Conclusion The high expression of c-myc may promote the invasion and metastasis of cervical cancer, and the high expression of bcat1 may promote the proliferation, invasion and metastasis of cervical cancer, which may have a synergistic effect in the pathogenesis of cervical cancer.

 

Keywords: c-myc bcat1, Cervical cancer, Clinicopathological characteristics, Synergistic effect 

 

 

Full Text:

PDF


References


DANG CV. Мус on the path to cancer. Cell, 2012, 149( 1); 22-35.

ZHOU W, FENG XL, REN CP, et al. Overexpression of BCAT1, a c-myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma. Mol Cancer, 2013, 12: 53-63 [ 2017-12-13 ]. https://doi. org/ 10. 1186/1476-4598-12-53.

TNJES M, BARBUS S, PARK YJ. et al. BCAT1 promotes cell proliferation through amino acid catabolisming liomas carrying wild-type IDH1. Nat Med.2013,19(7) :901-908.

MITHELL SM, ROSS JP. DREW HR, et al. A panel of genes methylated with high frequency in colorectal cancer. BMC Cancer,2014,14 ;54-68[2017-12-13]. https://doi. org/ 10. 1186/1471-2407-14-54.

ZHENG YH.HU WJXHEN ВС. BCAT1, a key prognostic predictor of hepatocellular carcinoma, promotes cell proliferation and induces chemoresistance to cisplatin. Liver Int,2016,36(12):1836-1847.

CHANG IW. WU WJ, WANG YH. et аl. BCAT1 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder. Histopathology,2016 ,68(4) :520-532.

CHEN S, YANG Z, ZHANG Y, et al. Genomic amplification patterns of human telomerase RNA gene and c- myc in liquid-based cytological specimens used for the detection of high-grade cervical intraepithelial neoplasia. Diagn Pathol, 2012, 7: 40 [ 2017-12-13 ]. https://doi. org/ 10. 1186/1746-1596-7-40.

KUBLERK, HEINENBERG S, RUDLOWSKI C, et al. c-myc copy number gain is a powerful prognosticator of disease outcome in cervical dysplasia. Oncotarget ,2014 ,6(2): 825-835.

FENG D. PENG С, LI C. et al. Indentification and characterization of cancer stem-like cells from primary carcinoma of the cervix ateri. Oncol Rep. 2009 , 22 ( 5 ): 1129- 1134.

CAPPELLEN D. SC H LANGE T.BAUER M.et al. Novel c- myc target genes mediate differential effects on cell proliferation and migration. EMBO Rep.2007,8( 1);70-76.

LINDSTROM AK. TOT T, STENDAHL U, et al. Discrepancies in expression and prognostic value of tumor markers in adenocarcinoma and squamous cell carcinoma in cervical cancer. Anticancer Res,2009,29(7) :2577-2578 .

KUGLIK P. KASIKOVA K. SMETANA J ,et al. Molecular cytogenetic analyses of hTERC (3q26) and myc (8q24) genes amplifications in correlation with oncogenic human papillomavirus infection in Czech patients with cervical

intraepithelial neoplasia and cervical carcinomas. Neoplasma. 2015,62(1):130-139.

KUJI S, HI RASH IMA Y. KOMEDA S, et al. The relationship between positive peritoneal cytology and the prognosis of patients with FIGO stage 1 / Ц uterine cervical cancer. J Gynecol Oncol,2014 ,25(2) ;90-96.

YAOY. LI C, ZHOU X, et al. PIWIL2 induces c-myc expression by interacting with NME2 and regulates c-myc- mediated tumor cell proliferation. Oncotarget, 2014 , 5 ( 18): 8466-8477.

CHANETON B, HILLMANN P, ZHENG L, et al. Serine is a natural ligand and allosteric activator of pyruvate kinase М2. Nature,2012,491(7424) :458-462.

BIBLE E. Neuro-oncology: BCAT1 promotes cell proliferation in aggressive gliomas. Nat Res' Neurol, 2013, 9 (8): 420 [2017-12-13]. https://www. nature, com/articles/ nrneurol. 2013. 135. doi;10. 1038/nrneurol. 2013. 135.

NIWA O, KUMAZAKI T.TSUKIYAMA T,et al. A cDNA clone overexpressed and amplified in a mouse teratocareinoma line. Nucleic Acids Res, 1990,18(22) :6709-6709.

COLE DJ,BROWN DC.CROSSLEY E.et at. Carcinoma of the cervix uteri; an assessment of the relationship of tumor proliferation to prognosis. Br J Cancer, 1992,65(5);783-785.

WANG ZQ, DNEN FADDAOUI A, BACH VAROVA M ,et al. BCAT1 expression associates with ovarian cancer progression; possible implications in altered disease metabolism. Oncotarget,2015,6(31);31522-31543.


Refbacks

  • There are currently no refbacks.